期刊
ACS APPLIED MATERIALS & INTERFACES
卷 11, 期 30, 页码 26745-26752出版社
AMER CHEMICAL SOC
DOI: 10.1021/acsami.9b10302
关键词
herpes simplex virus; polymeric inhibitors; PEG(x)-b-PMAPTAC(y); antiviral activity; polymer cell membrane interaction; in vitro and in vivo experiments
资金
- National Science Center, Poland [UMO-2014/13/B/ST5/04510, UMO-2012/07/E/NZ6/01712]
- Ministry of Science and Higher Education
A series of poly(ethylene glycol)-block-poly(3(-methacryloylamino)propyl trimethylammonium chloride) (PEG-b-PMAPTAC) water-soluble block copolymers consisting of PEG and PMPTAC were obtained by reversible addition-fragmentation chain transfer (RAFT) polymerization and demonstrated to function as highly effective herpes simplex virus type 1 (HSV-1) inhibitors as shown by in vitro tests (Vero E6 cells) and in vivo experiments (mouse model). Half maximal inhibitory concentration (IC50) values were determined by quantitative polymerase chain reaction to be 0.36 +/- 0.08 mu g/mL for the most effective polymer PEG(45)-b-PMAPTAC(52) and 0.84 +/- 1.24 mu g/mL for the less effective one, PEG(45)-b-PMAPTAC(74). The study performed on the mouse model showed that the polymers protect mice from lethal infection. The polymers are not toxic to the primary human skin fibroblast cells up to the concentration of 100 mu g/mL and to the Vero E6 cells up to 500 mu g/mL. No systemic or topical toxicity was observed in vivo, even with mice treated with concentrated formulation (100 mg/mL). The mechanistic studies indicated that polymers interacted with the cell and blocked the formation of the entry/fusion complex. Physicochemical and biological properties of PEG(x)-b-PMAPTAC(y) make them promising drug candidates.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据